A literature review on community-acquired methicillin-resistant Staphylococcus aureus in the United States: Clinical information for primary care nurse practitioners

Journal of the American Academy of Nurse Practitioners

Volumn 23, Issue 1, 2011, Pages 23-32

  Barnes, Barbara E ^a   Sampson, Deborah A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF NURSING   (United States)

Author keywords

Colonization; Community associated methicillin resistant Staphylococcus aureus; Infection prevention and control; Infectious disease; MRSA; Primary care nurse practitioner

Indexed keywords

ANTIINFECTIVE AGENT;

ATTITUDE TO HEALTH; CLINICAL COMPETENCE; COMMUNICABLE DISEASE; DRUG EFFECT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MULTIDRUG RESISTANCE; NURSE PRACTITIONER; NURSING; PRIMARY HEALTH CARE; REVIEW; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLINICAL COMPETENCE; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NURSE PRACTITIONERS; PRIMARY HEALTH CARE; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 78650918629     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2010.00571.x     Document Type: Review

References (93)

1. Al-Shawwa, B., & Wegner, D. (2005). Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children. Archives of Otolaryngology-Head & Neck Surgery, 131(9), 782-784.
2. Bartels, M., Boye, K., Larsen, A., Skov, R., & Westh, H. (2007). Rapid increase of genetically diverse meticillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerging Infectious Diseases, 13(10), 1533-1540.
3. Bell, E. (2008). Infectious Disease News. Antibiotic choices for CA-MRSA infections. Retrieved November 24, 2008, from
4. Boubaker, K., Diebold, P., Blanc, D., Vandenesch, F., Praz, G., & Dupuis, G. (2008). Panton-valentine leukocidin and staphylococcal skin infections in schoolchildren. Emerging Infectious Diseases, 10(1), 121-124. Retrieved March 15, 2009, from
5. Boyle-Vavra S., & Daum R. S. (2007). Community-acquired methicillin-resistant Staphylococcus aureus: The role of panton-valentine leukocidin. Laboratory Investigation, 87(1), 3-9.
6. Boyle-Vers, S., Ereshefsky, B., Wang, C., & Daum, R. (2005). Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus linage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type Vt or Sccmec type IV. Journal of Clinical Microbiology, 43(9), 4719-4730.
7. Bubacz, M. (2007). Community-acquired methicillin-resistant Staphylococcus aureus: An ever-emerging epidemic. AAOHN Journal, 55(5), 193-194.
8. Buescher, E. (2005). Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Clinical Infectious Diseases, 46(5), 5344-5349.
9. Calfee, D., Durbin, L., Germanson, T., Toney, D., Smith, E., & Farr, B. (2003). Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infection Control and Hospital Epidemiology, 24(6), 422-426.
10. Carleton, H., Diep, B., Charlebois, E., Sensabaugh, G., & Perdreau-Remington, F. (2004). Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases, 190, 1730-1736.
11. Cenizal, M., Skiest, D., Luber, S., Bedimo, R., Davis, P., Fox, P., et al. (2007). Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole of doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 51(7), 2628-2630.
12. Centers for Disease Control and Prevention (CDC). (1981). Community-acquired methicillin-resistant Staphylococcus aureus infections-Michigan. MMWR weekly, Epidemiologic Notes and Reports, 30(16), 185-187.
13. Centers for Disease Control and Prevention. (1999). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. Morbidity and Mortality Weekly Report, 48(32), 707-710.
14. Centers for Disease Control and Prevention. (2003). Methicillin-resistant Staphylococcus aureus in correctional facilities-Georgia, California, and Texas, 2001-2003. Department of Health and Human Services. MMWR weekly Report, 52(41), 992-996.
15. Centers for Disease Control and Prevention. (2006a). Management of multi-resistant organisms in the healthcare settings, 2006. Centers for Disease Control and Prevention. Department of Health and Human Services. Retrieved January 24, 2008, from
16. Centers for Disease Control and Prevention. (2006b). Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Department of Health and Human Services. Retrieved January 24, 2008, from
17. Centers for Disease Control and Prevention. (2007a). National Prevalence Study of methicillin-resistant Staphylococcus aureus. Department of Health and Human Services. Retrieved July14, 2008, from
18. Centers for Disease Control and Prevention. (2007b). Outpatient management of skin and soft tissue infections in the era of community-associated MRSA. Retrieved July 21, 2009, from
19. Centers for Disease Control and Prevention. (2008). Environmental management of staph and MRSA. Department of Health and Human Services. Retrieved January 09, 2009 from
20. Charlebois, E., Bangsber, D., Moss, N., Moore, M., Chambers, H., & Perdreau-Remington, F. (2002). Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clinical Infectious Diseases, 34, 425-432.
21. Cohen, P. (2005). Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. Southern Medical Association, 98(6), 596-602.
22. Cohen, A., Shuler, C., McAllister, Fosheim, G., Brown, M., Abercrombie, D., et al. (2007). Methamphetamine use and methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases, 13(11). Retrieved October 30, 2007, from
23. Conly, J., Stiver, H., Weiss, K., Becker, D., Rosner, A., & Miller, E. (2003). A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres. Canadian Journal of Infectious Diseases, 14(6), 315-320.
24. Cookson, B. (2000). Methicillin-resistant Staphylococcus aureus in the community: New battlefronts or are the battles lost Infection Control & Hospital Epidemiology, 21(6), 398-403.
25. D'Agata, E., Webb, G., Horn, M., Moellering, R., & Ruan, S. (2009). Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureas into hospitals. Clinical Infection Diseases, 48(30), 274-284.
26. Datta, R., & Huang, S. (2008). Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clinical Infectious Diseases, 47, 176-181.
27. Daum, R. (2007). Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Journal of the American Medical Association, 35(4), 380-390.
28. David, M., Crawford, S., Boyle-Vavra, S., Hostetler, M., Kim, D., & Daum, R. (2006). Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerging Infectious Diseases, 12(4), 631-637.
29. Davis, S., Perri, M., Donabedian, S., Manierski, C., Singh, A., Vager, D., et al. (2007). Epidemiology and outcomes of community-acquired methicillin-resistant Staphylococcus aureus Infection. Journal of Clinical Microbiology, 45(6), 1705-1711.
30. Dinusha, D., Auld, D., & Mermel, L. (2004). Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics, 113(4), 347-352.
31. Donnio, P., Preney, L., Gautiere-Lerestif, A., Avril, L., & Lafforgue, N. (2004). Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11 year period. Journal of Antimicrobial Chemotherapy, 53, 808-813.
32. Dooley, D., Barnes, E., Hepburn, J., & Baum, S. (2006). Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin. Military Medicine, 171, 504-507.
33. Duijkeren, E., Wolhagen, M., Box, A., Heck, M., Wim, J., Wannet, J., et al. (2004). Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases, 10(12), 2235-2237.
34. Ellis, M., Hospenthal, D., Dooley, D., Paula, J., & Clinton, K. (2004). Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clinical Infectious Diseases, 39(7), 971-979.
35. Eveillard, M., Lassence, A., Barnaud, G., Ricard, J., & Joly-Guillou, M. (2006). Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infection Control and Hospital Epidemiology, 27(2), 181-184.
36. Fergie, J., & Purcell, K. (2001). Community-acquired methicilllin-resistant Staphylococcus aureus infections in south Texas children. Pediatric Infectious Disease Journal, 20(9), 860-863.
37. Fridkin, S., Hageman, J., Morrison, M., Sanza, L., Como-Sabetti, K., Jernigan, J., et al. (2005). Methicillin-resistant Staphylococcus aureus in three communities. New England Journal of Medicine, 352(14), 1436-1444.
38. Gilbert, D., Moellering, R., Eliopoulos, G., Sande, M., & Chambers, H. (2008). The Sanford guide to antimicrobial therapy 2008 (38th ed.). Portland: Oregon Health Services University.
39. Gonzalez, B., Hulten, K., Dishop, M. Lamberth, l., Hammerman, W., Mason, E., et al. (2005). Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clinical Infectious Disease, 41, 583-590.
40. Gonzalez, B., Ruedia, A., Shelburne, S., Musher, D., Hamill, R., & Hulten, K. (2006). Community-associated strains of methicilllin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infection Control and Hospital Epidemiology, 27(10), 1051-1056.
41. Graham, P., Lin, S., & Larson, E. (2006). A U.S. population-based survey of Staphylococcus aureus colonization. Annals of Internal Medicine, 144, 318-325.
42. Groom, A., Wolsey, D., Naimi, T., Smith, K., Johnson, S., Boxrud, D., et al. (2001). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. Journal of the American Medical Association, 286(10), 1201-1207.
43. Halem, M., Trent, J., Green, J., & Kerdel, F. (2006). Community-acquired methicillin resistant Staphylococcus aureus skin infection. Seminars in Cutaneous Medicine and Surgery, 25(2), 68-71.
44. Herold, B., Immergluck, L., Maranan, M., Lauderdale, K., Gaskin, R., Boyle-Vavra, S., et al. (2007). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of the American Medical Association, 279(8), 593-598.
45. Hersh, L., Cabana, M., Gonzales, R., Shenkin, B., & Cho, C. (2009). Pediatricians' perspectives on the impact of MRSA in primary care: A qualitative study. BMC Pediatrics 9(27). Retrieved July 21, 2009, from
46. Hidron, A., Low, C., Honig, E., & Blumberg, H. (2009). Emergence of community-acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotizing community onset pneumonia. Lancet Infectious Diseases, 9, 384-392.
47. Hinckley, J., & Allen, P. (2008). Community-associated MRSA in the pediatric primary care setting. Pediatric Nursing. Retrieved July 21, 2009, from
48. Holby, N., Pers, C., Johansen, H., & the Copenhagen study group of Antibiotics in Sweat. (2000). Excretion of B-lactam antibiotics in sweat-a neglected mechanism for development of antibiotic resistance Antimicrobial Agents and Chemotherapy, 44(10), 2855-2857.
49. Hota, B., Ellenbogen, C., Hayden, M., Aroutcheva, A., Rice, T., & Weinstein, R. (2007). Community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital. Arch Intern Med, 167, 1026-1033.
50. Hulten, K., Kaplan, S., Gonzalez, B., Hammerman, W. Lamberth, L., Versalovic, J., et al. (2006). Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatric Infectious Disease Journal, 25(4), 39-353.
51. Illinois Department of Public Health (IDPH). (2008). Methicillin-resistant Staphylococcus aureus in Illinois: Guidelines for the primary care provider. Infectious Disease in Illinois. Retrieved January 9, 2009, from
52. Iyer, S., & Jones, D. (2004). Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. Journal of the American Academy of Dermatology, 50(6), 854-858.
53. Jernigan, J., Pullen, A., Partin, C., & Jarvis, W. (2003). Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infection Control and Hospital Epidemiology, 24(6), 445-450.
54. Jevons, M. (1961). Celbenin resistant staphylococci. British Medical Journal, 1, 124-127.
55. Kenner, J., O'Conner, T., Piantanida, N., Fishbain, J., Eberly, B., Viscount, H., et al. (2003). Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infection Control and Hospital Epidemiology, 24(6), 439-444.
56. Kim, G, & Del Rosso, J. (2008). Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections: Evaluation and management strategies. Skin and Aging. Retrieved January 10, 2008, from
57. Kiran, R. V., McCampbell, B., Angeles, A., Montilla, R., Medina, C., Richard, D., et al. (2006). Increased prevalence of community-acquired methicillin-resistant Staphylococcus aureus in hand infections at an urban medical center. Plastic and Reconstructive Surgery, 118(1), 161-167.
58. Klevens, R., Morrison, M., Nadle, J., Petit, S., Gershman, K., Ray, S., et al. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association, 298(15), 1763-1771.
59. Kuehnert, M., Kruszon-Moran, D., Hill, H., McQuillan, G., McAllister, S., Fosheim, G., et al. (2006). Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. Journal of Infectious Diseases, 193, 171-179.
60. Lee, M., Rios, A., Aten, M., Mejias, A., Cavuoti, D., Mccracken, Jr., G., et al. (2004). Community-acquired, methicillin-resistant and methicllin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatric Infectious Disease Journal, 25(8), 701-706.
61. Lee, N., Taylor, M., Bancroft, E., Ruane, P., Morgan, M., McCoy, L., et al. (2005). Risk factors for community associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clinical Infectious Diseases, 40, 1529-1534.
62. Loffler, C., & MacDougall, C. (2007). Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert Review of Anti-infective Therapy, 5(6), 961-981.
63. Manian, F. (2003). Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clinical Infectious Diseases, 36(2), E26-E28.
64. Marcinak, J., & Frank, A. (2003) Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Current Opinion in infectious Diseases, 16(3), 265-270.
65. Maree, C., Daum, R., Boyle-Vavra, S., Matayoshi, K., & Miller, L. (2007). Community-associated methicilllin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerging Infectious Diseases, 13(2), 236-242. Retrieved June 1, 2008, from
66. Martinez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, Jr., E., & Kaplan, S. (2004). Clindamycin treatment of invasive infections cause by community-acquired methicillin resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatric Infectious Disease Journal, 22(7), 593-598.
67. Micek, S., Dunne, M., & Kollef, M. (2005). Pleuropulmonary complications of panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: Importance of treatment with antimicrobials inhibiting exotoxin production. Chest, 128(4), 2732-2738.
68. Milhoces, G. (2005). Teams keep eye on turf abrasions, staph infections. USA Today. Super Bowl XL. Retrieved October 10, 2008, from
69. Miller, L., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A., et al. (2005). Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. New England Journal of Medicine, 352(14), 1445-1447.
70. Miller, L., Quan, C., Shay, A., Mostafaie, K., Bhardwa, K., Tan, N., et al. (2007). A prospective investigation of outcomes after hospital discharge for endemic, community acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clinical Infectious Diseases, 44(15), 971-979.
71. Moran, G., Amii, R., Abrahamian, F., & Talan, D. (2005). Methicillin-resistant Staphylococcus aureus in community acquired skin infections. Emerging Infectious Diseases, 11(6), 928-930.
72. Moran, G., Krishnadasan, A., Gorwitz, R., Fosheim, G., McDougal, L., Carey, R., et al. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine, 355, 664-674.
73. Naimi, T., LeDell, K., Como-Sabeti, K., Borchards, S., Boxrud, D., Etienne, J., et al. (2003). Comparison of community- and health care-associated methicillin resistant Staphylococcus aureus infection. Journal of the American Medical Association, 290(22), 2976-2984.
74. National Nosocomial Infections Surveillance. (2002). System report, data summary from January 1992-June 2002, issued August 2002. American Journal of Infection Control, 30, 458-475.
75. Ochoa, T., Mohr, J., Wanger, A., Murphy, J., & Heresi, G. (2005). Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerging Infectious Diseases, 11(6), 966-968.
76. Ofner-Agostini, M., Simore, A., Bryce, E., McGeer, A., & Paton, S. (2006). Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infection Control and Hospital E, Epidemiology, 27(2), 204-207.
77. Purcell, K., & Fergie, J. (2005). Epidemic of community-acquired methicilllin-resistant Staphylococcus aureus infections: A 14-year study at Driscoll children's hospital. Archive of Pediatrics and Adolescent Medicine, 159(10), 980-985.
78. Rejendran, P., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., et al. (2007). Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapy, 51(11), 4044-4048.
79. Rihn, J., Posfay-Barbe, K., Harner, C., Macurak, A., Farley, A., Greenawalt, K., et al. (2005). Community-acquired methicilllin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful intervention. Pediatric Infectious Disease Journal, 24(9), 841-843.
80. Robinson, D., Kearns, A., Holmes, A., Morrison, D., Grundmann, H., Edwards, G., et al. (2005). Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet, 365, 1256-1258.
81. Rybak, M., Lomaestro, B., Roschafer, J., Moellering, R., Craig, W., Billeter, M., et al., (2009). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Disease Society of America, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacists, 66, 82-98.
82. Salgado, C., Farr, B., & Calfee, D. (2003). Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clinical Infectious Diseases, 36, 131-139.
83. Sattler, C., Mason, Jr., E., & Kaplan, S. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatric Infectious Disease Journal, 21(10), 910-916.
84. Simor, A., Philips, E., McGee, A., Konalinka, A., Loeb, M., Devlin, R., et al. (2007). Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clinical Infectious Disease, 44, 178-184.
85. Stevens, D., Bisno, A., Chambers, H., Everett, E., Dellinger, P., Goldstein, E., et al. (2005). Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clinical Infectious Diseases, 41, 1371-1830.
86. Stevenson, K., Searle, K., Stoddard, G. & Samore, M. (2005). Methicilllin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in rural communities, western United States. Emerging Infectious Diseases, 11(6), 895-903.
87. Vandenesch, F., Naimi, T., Enright, M., Lina, G., Nimmo, F., Heffernan, H., et al. (2003). Community-acquired methicillin resistant Staphylococcus aureus carrying panton-valentine leukocidin genes: Worldwide emergence. Emerging Infectious Diseases, 9(8), 978-984.
88. Wannet, W., Heck, M., Pluister, G., Spalburg, E., Santen, M., Huijsdens, X., et al. (2004). Panton-valentine leukocidin positive MRSA in 2003: The Dutch situation. Europosurveillance, 12(2), 1202-1222.
89. Wang, R., Braughton, K., Kretschmer, D., Bach, T., Queck, S., Li, M., et al. (2007). Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine, Letters. Advance online publication. Retrieved February 22, 2008, from
90. Weese, S., Dick, H., Willey, B., McGeer, A., Kreiswirth, B., Innis, B., et al. (2006). Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Veterinarian Microbiology, 115(1-5), 148-155.
91. Winland-Brown, J., Porter, B., & Leik, M. (2007). Skin problems. In L. M. Dunphy, J. W. Brown, B. O. Porter, & D. J. Thomas (Eds.), Primary care: The art and science of advanced practice nursing (pp. 131-228). Phildelphia: F.A. Davis Company.
92. Zafar, U., Johnson, L, Hanna, M., Riederer, K., Sharma, M., Fakih, M., et al. (2007). Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infection Control and Hospital Epidemiology, 28(6), 966-969.
93. Zaoutis, T., Toltzis, P., Chu, J., Abrams, T., Dul, M., Kim, J., et al. (2006). Clinical and molecular epidemiology of community-acquired methicilllin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatric Infectious Disease Journal, 25(4), 343-348.